Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

EMA validates MAA for Xyndari for sickle cell disease

March 13, 2018

Sigilon Therapeutics' SIG-003 awarded EMA ATMP designation

March 12, 2018

FDA grants orphan drug designation to PTG-300 for beta-thalassemia

March 7, 2018

IRP1 targeting ameliorates Chuvash polycythemia in mice

March 2, 2018

European Commission approves Hemlibra

Feb. 28, 2018

Novo Nordisk submits regulatory applications for N8-GP in U.S. and E.U.

Feb. 28, 2018

FDA grants priority review to lusutrombopag NDA

Feb. 27, 2018

EMA committee recommends change to marketing authorization terms for Feraccru

Feb. 26, 2018

Overall survival improved with OMS-721 in thrombotic microangiopathy trial

Feb. 16, 2018

Oxford BioMedica enters collaboration and license agreement with Bioverativ in hemophilia

Feb. 15, 2018